A pharmaceuticals giant is making redundancies at its Stevenage site as part of a global restructuring programme.
GlaxoSmithKline announced in December that it’s changing its research and development organisation, which will mean jobs losses in the coming months, but says it’s still committed to the future of the Gunnels Wood Road site.
A spokesman for the firm said: “While there will be some job losses we’re also making investments and building new capabilities that will create new roles.
“We will be doing all we can to minimise job losses, including supporting those displaced from current roles to apply for the new ones being created.
“We’re committed to continuing our significant research and development operations in the Stevenage area – it’s one of our two global centres and critical to the future of our medicines pipeline.”
The restructuring programme also aims to modernise the firm’s research and development programme.
It is not currently known how many redundancies will be required.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here